Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 110

Principia goes public in $106m IPO

The GSK-backed small molecule drug developer floated at the top of its range to raise just over $106m.

Sep 17, 2018

Anaplan approaches public markets with $100m IPO filing

The connected planning software provider has raised a total of $300m from investors including Salesforce and Workday and was valued at $1.4bn in 2017.

Sep 17, 2018

Tuhu tunes into $450m series E

Tencent came on board as a Tuhu investor and strategic partner in a series E round that followed a Baidu-backed round two years ago.

Sep 17, 2018

IP Group sparks Flint’s interest

Douglas Flint has been appointed as chairman of IP Group, taking over from Mike Humphrey on November 1.

Sep 17, 2018

Orange pays attention as Yoco raises $16m

Payment technology provider Yoco has secured funding in a series B round led by Partech Ventures with backing from Orange Digital Ventures.

Sep 16, 2018

ING and SCG feed Black Bear

Tire recycling technology provider Black Bear Carbon has received $12.8m in a round backed by both corporates.

Sep 16, 2018

Boehringer Ingelheim greets ViraTherapeutics in $245m purchase

Cancer drug developer ViraTherapeutics has been acquired by Boehringer Ingelheim, three years after the corporate led its series A round.

Sep 14, 2018

Packet opens up to let in $25m

Samsung Next, JA Mitsui Leasing and existing investors SoftBank and Dell Technologies Capital all chipped in to Packet's series B round.

Sep 14, 2018

Epic applies itself to $52m series E

Oncology diagnostics technology developer Epic Sciences, whose investors include Genomic Health, Pfizer and Roche, has now raised at least $135m in total.

Sep 14, 2018

Westwing to take flight in $139m IPO

Rocket Internet-backed online furniture retailer Westwing aims to raise $139m in an initial public offering in Frankfurt.

Sep 14, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here